Texere Biotech launches world's first fully robotic bone allograft processing line

Charleroi (BE), 12 December 2018, 17:30 PM CET

TEXERE Biotech, a Belgian-based biotech company specializing in human tissue processing, is today inaugurating the world’s first fully robotic and most advanced processing line for the production of orthobiologics bone allograft. As the source of the product is donated tissue, it is extremely important to maximize the yield in order to increase the availability to patients. The TEXERE process (known as “smart factory-industry 4.0 type”) increases tissue recovery by a factor of 2 to 3 compared with existing processes. At the same time, it offers a superior product quality, with increased medical safety, and does so at a reduced cost. Discover the official press release here.

MaSTherCell expands production by doubling its capacity

GOSSELIES, BELGIUM – November 30, 2018 – MaSTherCell S.A. a subsidiary of Orgenesis Inc. (NASDAQ: ORGS) through Masthercell Global Inc., a cell therapy-dedicated Contract Development and Manufacturing Organization (CDMO) launched a new production wing of 600 m² at its Belgium site in the presence of the Minister-President of Wallonia, Willy Borsus. Masthercell is also backed by Great Point Partners, LLC (“GPP”), a leading healthcare investment firm based in Greenwich, Connecticut. Discover the official press release here